Hyperresponsiveness of vitamin D receptor gene expression to 1,25- dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone- forming rats

Journal of Clinical Investigation

Volumn 101, Issue 10, 1998, Pages 2223-2232

  Yao, Jianling ^a   Kathpalia, Paru ^a   Bushinsky, David A ^b   Favus, Murray J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

1,25(OH)2D3; Gene expression; Hypercalciuria; Rat; Vitamin D receptor

Indexed keywords

CALBINDIN; CALCITRIOL; CALCIUM; CYCLOHEXIMIDE; DACTINOMYCIN; VITAMIN D RECEPTOR;

ARTICLE; CALCIUM ABSORPTION; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONE RECEPTOR INTERACTION; HYPERCALCIURIA; MALE; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; TISSUE SPECIFICITY; VITAMIN BLOOD LEVEL;

EID: 0032523911     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1164     Document Type: Article

References (50)

1. Hodgkinson, A., and L.N. Pyrah. 1958. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stones of renal origin. Br. J. Surg. 46: 10-18.
2. Robertson, W.G., M. Peacock, and B.E.C. Nordin. 1968. Activity products in stone-forming and non-stone-forming urine. Clin. Sci. (London). 34: 579-594.
3. Hodgkinson, A. 1974. Relations between oxalic acid, calcium, magnesium, and creatinine excretion in normal men and male patients with calcium oxalate kidney stones. Clin. Sci. Mol. Med. 46:357-367.
4. Monk, R.D., and D.A. Bushinsky. 1996. Pathogenesis of idiopathic hypercalciuria. In Kidney Stones: Medical and Surgical Management. F.L. Coe, M.J. Favus, C.Y.C. Pak, J.H. Parks, and G.M. Premminger, editors. Lippincott-Raven Publishers, Philadelphia. 759-772.
5. Lemann, J., Jr. 1992. Pathogenesis of idiopathic hypercalciuria and nephrolithiasis. In Disorders of Bone and Mineral Metabolism. F.L. Coe and M.J. Favus. editors. Raven Press, Ltd. New York. 685-706.
6. Liberman, U.A., O. Sperling, A. Atsmon, M. Frank, M. Modan, and A. DeVries. 1968. Metabolic and calcium kinetic studies in idiopathic hypercalciuria. J. Clin. Invest. 47:2580-2590.
7. Pak, C.Y.C., M. Ohata, E.C. Lawrence, and W. Snyder. 1974. The hypercalciurias: causes, parathyroid functions, and diagnostic criteria. J. Clin. Invest. 54:387-400.
8. 45Ca in stone-forming patients. Br. J. Med. 1:427-429.
9. Insogna, K.L., A.E. Broadus, B.E. Dreyer, A.F. Ellison, and J.M. Gertner. 1985. Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria. J. Clin. Endocrinol. Metab. 61:490-495.
10. Breslau, N.A., G.M. Premminger, B.V. Adams, J. Otey, and C.Y.C. Pak. 1992. Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria. J. Clin. Endocrinol. Metab. 75: 1446-1452.
11. Kaplan, R.A., M.R. Haussler, L.J. Deftos, H. Bone, and C.Y.C. Pak. 1977. The role of 1,25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J. Clin. Invest. 59:756-760.
12. Shen, F.H., D.J. Baylink, R.L. Nielsen, D.J. Sherrard, J.L. Ivey, and M.R. Haussler. 1977. Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria. J. Lab. Clin. Med. 90:955-962.
13. Barilla, D.E., R. Tolentino, R.A. Kaplan, and C.Y.C. Pak. 1978. Selective effects of thiazide on intestinal absorption of calcium in absorptive and renal hypercalciurias. Metabolism. 27:125-131.
14. Van Den Berg, C.J., R. Kumar, D.M. Wilson, H. Heath III, and L.H. Smith. 1980. Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria. J. Clin. Endocrinol. Metab. 51:998-1001.
15. 3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am. J. Med. 72:25-32.
16. Broadus, A.E., K.L. Insogna, R. Lang, A.F. Ellison, and B.E. Dreyer. 1984. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N. Engl. J. Med. 311:73-80.
17. Sutton, R.A.L., and V.R. Walker. 1980. Responses to hydrochlorothiazide and acetazolamide in patients with calcium stones: evidence suggesting a defect in renal tubular function. N. Engl. J. Med. 302:709-713.
18. Bushinsky, D.A., and M.J. Favus. 1988. Mechanism of hypercalciuria in genetic hypercalciuric rats. Inherited defect in intestinal calcium transport. J. Clin. Invest. 82:1585-1591.
19. Li, X.Q., V.A. Tembe, G.M. Horwitz, D.A. Bushinsky, and M.J. Favus. 1993. Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption. J. Clin. Invest. 91:661-667.
20. Kim, M., N.E. Sessler, V. Tembe, M.J. Favus, and D.A. Bushinsky. 1993. Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int. 43: 189-196.
21. 3 in bone from genetic hypercalciuric rats. Am. J. Physiol. 271:C130-C135.
22. Tsuruoka, S., D.A. Bushinsky, and G.J. Schwartz. 1997. Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int. 51:1540-1547.
23. 3 receptor. Cancer Res. 44:2103-2109.
24. 3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses. Endocrinology. 118:250-259.
25. 3 metabolism limits receptor occupancy and target tissue responsiveness. J. Biol. Chem. 264:15917-15921.
26. 3 receptor turnover by dense amino acid labeling: changes during receptor up-regulation by vitamin D metabolites. Endocrinology. 120:1173-1178.
27. Favus, M.J., D.J. Mangelsdorf, V. Tembe, B.J. Coe, and M.R. Haussler. 1988. Evidence for in vivo upregulation of the intestinal vitamin D receptor during dietary calcium restriction in the rat. J. Clin. Invest. 82:218-224.
28. Favus, M.J., and F.L. Coe. 1979. Evidence for spontaneous hypercalciuria in the rat. Miner. Electrolyte Metab. 2:150-154.
29. Bushinsky, D.A., M.D. Grynpas, E.L. Nilsson, Y. Nakagawa, and F.L. Coe. 1995. Stone formation in genetic hypercalciuric rats. Kidney Int. 48:1705-1713.
30. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
31. Yao, J., and M. Eghbali. 1992. Decreased collagen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy: response of cardiac fibroblasts to thyroid hormone in vitro. Circ. Res. 71:831-839.
32. Yao, J., R.C. Bone, and R. Sawhney. 1995. Differential effect of tumor necrosis factor-alpha on the expression of fibronectin and collagen genes in cultured bovine endothelial cells. Cell. Mol. Biol. Res. 41:17-28.
33. Yao, J., T.T. Giant, M.W. Lark, K. Mikecz, J.J. Jacobs, N.I. Hutchinson, L.A. Hoerrner, K.E. Kuettner, and J.O. Galante. 1995. The potential role of fibroblasts in periprosthetic osteolysis: fibroblast response to titanium particles. J. Bone Miner. Res. 10:1417-1427.
34. McDonnell, D.P., D.J. Mangelsdorf, J.W. Pike, M.R. Haussler, and B.W. O'Malley. 1987. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science. 235:1214-1217.
35. 9k cDNA from mouse placenta. In Vitamin D: Molecular, Cellular and Clinical Endocrinology. Seventh Workshop on Vitamin D. A.W. Norman, K. Schaefer, H.G, Crigoleit, and D. Harrath, editors. Walter de Gruyter & Co., Berlin. 507-508.
36. 28k RNAs in rodent brain and kidney. DNA (NY). 7:585-593.
37. Snedecor, G.W., and W.G. Cochran. 1980. Regression. In Statistical Methods. G.W. Snedecor and W.G. Cochran, editors. Iowa State University Press, Ames, IA. 149-174.
38. Snedecor, G.W., and W.G. Cochran. 1980. Two-way classifications. In Statistical Methods. G.W. Snedecor and W.G. Cochran, editors. Iowa State University Press, Ames, IA. 255-273.
39. 3 receptor. Proc. Natl. Acad. Sci. USA. 85:9499-9502.
40. Kaufman, P.B., W. Wu, D. Kim, and L.J. Cseke. 1995. DNA sequencing. In Handbook of Molecular and Cellular Methods in Biology and Medicine. CRC Press, Inc., Boca Raton, FL. 211-242.
41. Lowe, K.E. 1992. Vitamin D-mediated gene expression. Crit. Rev. Eukaryotic Gene Expr. 2:65-109.
42. 3 receptor in vivo. Proc. Natl. Acad. Sci. USA. 86:9770-9773.
43. 3 in the parathyroid in vivo. J. Clin. Invest. 86:1968-1975.
44. Sriussadaporn, S., M.S. Wong, J.W. Pike, and M.J. Favus. 1995. Tissue specificity and mechanism of vitamin D receptor up-regulation during dietary phosphorus restriction in the rat. J. Bone Miner. Res. 10:271-280.
45. 3 receptor gene: comparison with calbindin gene expression. J. Biol. Chem. 264:17454-17461.
46. Dupret, J.M., P. Brun, C. Perret, N. Lomri, M. Thomasset, and P. Cuisinier-Gleizes. 1987. Transcriptional and post-transcriptional regulation of vitamin D-dependent calcium-binding protein gene expression in the rat duodenum by 1,25-dihydroxycholecalciferol. J. Biol. Chem. 262:16553-16557.
47. Yao, J., M.S. Wong, D.A. Bushinsky, and M.J. Favus. 1996. Altered regulation of calbindin gene expression in genetic hypercalciuric rats. J. Bone Miner. Res. 11:S373. (Abstr.)
48. 28K gene expression. J. Biol. Chem. 263:9776-9784.
49. 3-replete chick intestine. J. Biol. Chem. 261:7311-7315.
50. 9k. In Vitamin D. D. Feldman, F.H. Glorieux, and J.W. Pike, editors. Academic Press, Inc., San Diego. 223-232.